|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 252.95 USD | -0.45% |
|
-3.61% | +36.94% |
| 12/06 | Sector Update: Health Care Stocks Lean Lower Premarket Thursday | MT |
| 12/06 | BeOne Medicines Ltd Showcases Breakthrough Data in CLL and MCL at EHA 2025 | CI |
| Capitalization | 32.21B 27.97B 26.32B 23.91B 44.08B 2,784B 49.39B 309B 119B 1,273B 121B 118B 4,658B | P/E ratio 2025 * |
162x | P/E ratio 2026 * | 38.1x |
|---|---|---|---|---|---|
| Enterprise value | 30.42B 26.41B 24.85B 22.58B 41.62B 2,629B 46.64B 292B 113B 1,202B 114B 112B 4,398B | EV / Sales 2025 * |
5.96x | EV / Sales 2026 * | 4.81x |
| Free-Float |
96.17% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: BeOne Medicines Ltd.
More recommendations
More press releases
More news
| 1 day | -0.45% | ||
| 1 week | -3.61% | ||
| Current month | +3.00% | ||
| 1 month | +10.76% | ||
| 3 months | -3.23% | ||
| 6 months | +43.83% | ||
| Current year | +36.94% |
| 1 week | 249.52 |  | 272.82 |
| 1 month | 232.78 | | 284.51 |
| Current year | 172.67 | | 287.88 |
| 1 year | 141.31 | | 287.88 |
| 3 years | 124.46 | | 287.88 |
| 5 years | 118.18 | | 426.56 |
| 10 years | 22.51 | | 426.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Oyler
CEO | Chief Executive Officer | 56 | 28/10/2010 |
Xiao Bin Wu
PSD | President | 63 | 01/04/2018 |
Aaron Rosenberg
DFI | Director of Finance/CFO | 49 | 22/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
John Oyler
CHM | Chairman | 56 | 27/01/2016 |
Michael Goller
BRD | Director/Board Member | 50 | 01/04/2015 |
Ranjeev Krishana
BRD | Director/Board Member | 51 | 01/10/2014 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.45% | -3.61% | +63.51% | +91.43% | 32.38B | ||
| -0.04% | -3.02% | +17.32% | +12.55% | 48.55B | ||
| -18.96% | +285.80% | +58,645.35% | +5,549.30% | 38.57B | ||
| +0.33% | -2.66% | -27.36% | -21.50% | 26.66B | ||
| +0.31% | +0.06% | -1.04% | +20.47% | 26.1B | ||
| -0.23% | +1.48% | +13.47% | -17.84% | 12.55B | ||
| -1.48% | -2.41% | +127.74% | - | 12.14B | ||
| +1.11% | -1.45% | -54.99% | -28.60% | 11.27B | ||
| -1.27% | -0.59% | +38.57% | +103.42% | 10.44B | ||
| 0.00% | -0.36% | +3.44% | +0.48% | 10.08B | ||
| Average | -1.87% | +37.28% | +5,882.60% | +634.41% | 22.87B | |
| Weighted average by Cap. | -3.19% | +62.89% | +9,904.53% | +1,006.90% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.1B 4.43B 4.17B 3.79B 6.98B 441B 7.82B 48.94B 18.91B 202B 19.14B 18.74B 738B | 6.17B 5.36B 5.04B 4.58B 8.44B 533B 9.46B 59.2B 22.88B 244B 23.16B 22.67B 892B |
| Net income | 131M 113M 107M 96.99M 179M 11.29B 200M 1.25B 484M 5.17B 490M 480M 18.9B | 609M 529M 498M 452M 834M 52.66B 934M 5.85B 2.26B 24.09B 2.29B 2.24B 88.11B |
| Net Debt | -1.79B -1.56B -1.47B -1.33B -2.45B -155B -2.75B -17.2B -6.65B -70.9B -6.73B -6.59B -259B | -2.55B -2.21B -2.08B -1.89B -3.48B -220B -3.9B -24.43B -9.44B -101B -9.56B -9.35B -368B |
More financial data
* Estimated data
Employees
11,000
Calendar
26/06
- R&D Day
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/06/25 | 252.78 $ | -0.52% | 230,442 |
| 17/06/25 | 254.09 $ | -3.91% | 424,802 |
| 16/06/25 | 264.42 $ | -1.93% | 326,675 |
| 13/06/25 | 269.63 $ | -2.50% | 391,803 |
| 12/06/25 | 276.53 $ | +5.38% | 724,422 |
Delayed Quote Nasdaq, 19 June 2025 at 05:59 am AEST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
252.78USD
Average target price
331.97USD
Spread / Average Target
+31.33%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ONC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition